<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-25T11:10:46+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>源兴基因，病毒载体商业化制备的引领者丨医麦猛爆料</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/SZlqcBNAp-Q_y449czxF2Q</id>
    <link href="https://mp.weixin.qq.com/s/SZlqcBNAp-Q_y449czxF2Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>方达沙龙｜“药物研发生物分析和注册申报要点”广州站（第三轮通知）</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/qwN9bhLCpSq8M_wWVXd7OA</id>
    <link href="https://mp.weixin.qq.com/s/qwN9bhLCpSq8M_wWVXd7OA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>备受制药巨头和资本青睐的TCR领域，迎来首个积极的Ⅲ期临床结果丨医麦新观察</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/ANAMNg_N_neu7Oi_h9Uu8g</id>
    <link href="https://mp.weixin.qq.com/s/ANAMNg_N_neu7Oi_h9Uu8g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>现货型CAR-NK新贵获4200万美元融资，NK细胞在癌症治疗领域的潜力大开发 | 医麦猛爆料</title>
    <updated>2020-11-24T22:57:19+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/BZZQFXt_-XLP_t6wk5Zn6Q</id>
    <link href="https://mp.weixin.qq.com/s/BZZQFXt_-XLP_t6wk5Zn6Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>热点解读｜Claudin 18.2-下一个肿瘤免疫治疗 / 伴随诊断新热点</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/A-IZwiWknD16jN5GdOg8Ig</id>
    <link href="https://mp.weixin.qq.com/s/A-IZwiWknD16jN5GdOg8Ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>疫情防控常态化，医疗策略精准化 | 2020 精准医学产业化（上海）高峰论坛圆满落幕</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/8XG_ZFi1cLk9lPhcnrAs3w</id>
    <link href="https://mp.weixin.qq.com/s/8XG_ZFi1cLk9lPhcnrAs3w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>郝思国教授：双份脐血移植治疗恶性血液肿瘤疗效确切、复发率低，值得进一步临床对照研究</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/YPIfjkeXVfLvEYz_iK0b9A</id>
    <link href="https://mp.weixin.qq.com/s/YPIfjkeXVfLvEYz_iK0b9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」华盖医疗合伙人张翼：与药企共同成长，迈入国际一线阵营</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/syYfIK7ZPyJ7UlIvJMnMoA</id>
    <link href="https://mp.weixin.qq.com/s/syYfIK7ZPyJ7UlIvJMnMoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>目标DMD！礼来公司1.35亿美元门票入场基因编辑领域丨医麦猛爆料</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/-WJCYUvNzY3gYgwX_Bu3ng</id>
    <link href="https://mp.weixin.qq.com/s/-WJCYUvNzY3gYgwX_Bu3ng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内最新100项干细胞临床研究备案项目汇总丨星耀研究院</title>
    <updated>2020-11-24T19:56:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/Ya-vBfrr6MLvUDWcQ1Lu_w</id>
    <link href="https://mp.weixin.qq.com/s/Ya-vBfrr6MLvUDWcQ1Lu_w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CBioPC 2020重磅亮相丨生物制药领域热门细分赛道，赛默飞整体解决方案全面覆盖</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/_drxtXXFaxmI4-g_H6A0Lg</id>
    <link href="https://mp.weixin.qq.com/s/_drxtXXFaxmI4-g_H6A0Lg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大国博弈下生物医药行业的破局之法-峰客独家访谈Mann Fung博士</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/kkDxoCib6sqqpVgNMNySIg</id>
    <link href="https://mp.weixin.qq.com/s/kkDxoCib6sqqpVgNMNySIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺奖得主创办的公司达成最新合作，进一步推进异体CD371 CAR-T研究丨医麦猛爆料</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/3RGSOpRZQPvEnr9AoZiKcw</id>
    <link href="https://mp.weixin.qq.com/s/3RGSOpRZQPvEnr9AoZiKcw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>倒计时1天！2020精准医学产业化(上海)高峰论坛即将在上海开幕</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/lD2IBPwpMWwjS0GtG0zoWw</id>
    <link href="https://mp.weixin.qq.com/s/lD2IBPwpMWwjS0GtG0zoWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>慢病毒造血干细胞基因疗法获美国FDA批准临床，在欧洲即将进入商业化阶段丨医麦猛爆料</title>
    <updated>2020-11-23T09:21:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/P0cTF-DZ3As15uz7wvNVnA</id>
    <link href="https://mp.weixin.qq.com/s/P0cTF-DZ3As15uz7wvNVnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>非小细胞肺癌免疫治疗新突破，显著延长患者无进展生存期，降低疾病进展或死亡风险50%！丨医麦猛爆料</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/C8C4_4yEpjiu4UdCt9AbBA</id>
    <link href="https://mp.weixin.qq.com/s/C8C4_4yEpjiu4UdCt9AbBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>东曜药业亮相ESMO ASIA，首次公布贝伐珠单抗注射液III期研究结果丨医麦猛爆料</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/bTRRwtVrgxlsskZ__d7qMA</id>
    <link href="https://mp.weixin.qq.com/s/bTRRwtVrgxlsskZ__d7qMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IL-15装甲的可控TIL疗法即将启动！更强的抗肿瘤活性和安全性丨医麦猛爆料</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/qzqFT4DumHCkbDEgGKzWWA</id>
    <link href="https://mp.weixin.qq.com/s/qzqFT4DumHCkbDEgGKzWWA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈方平教授：基因治疗遗传性血液病疗效令人振奋，未来进入临床应用可期可待</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/FoNf1olGvzgjNaMNesF4kw</id>
    <link href="https://mp.weixin.qq.com/s/FoNf1olGvzgjNaMNesF4kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨生物技术领域投资市场巨大，千万级投资已是平常</title>
    <updated>2020-11-22T17:05:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/XhCC_BV6QKpH41M2LnIAvA</id>
    <link href="https://mp.weixin.qq.com/s/XhCC_BV6QKpH41M2LnIAvA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>